Marjan Cruijsen (M Cruijsen)

Years Active: 2020-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Marjan Cruijsen, Jacobien R Hilberink, Walter J F M van der Velden, Joop H Jansen, Brigitte Bär, Nicolaas P M Schaap, Anton de Haan, André B Mulder, Marco R de Groot, Frédéric Baron, Edo Vellenga, Nicole N M Blijlevens, Gerwin Huls
Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation. Bone marrow transplantation 56 (8) (2021)
Marjan Cruijsen, W J F M van der Velden, A F J de Haan, S K Klein, M Hoogendoorn, Y Tromp, B de Valk, B van Rees, F de Boer, E van der Spek, J Pruijt, L F Verdonck, Edo Vellenga, Nicole M A Blijlevens, A A van de Loosdrecht, G Huls
Use of azacitidine and its safety and efficacy in daily clinical practice in The Netherlands: the OCEAN study. Leukemia & lymphoma 61 (11) (2020)

Marjan Cruijsen.css-eqlu8i{font-size:small;padding-left:4px;} (M Cruijsen)